Company / Depreciation & Amortization
Emergent BioSolutions Inc. Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$95.8M
FY2025
5-year range
$95.8M / $143.3M
FY2021-FY2025
Trend
-11.9%
vs FY2024
Sector context
#17 of 168
Health Care
What the data says
Among 168 Health Care companies, Emergent BioSolutions Inc. is in the bottom 10% for depreciation & amortization. Depreciation & Amortization has declined for 3 consecutive years, from $143M in FY2022 to $96M in FY2025.
Based on SEC 10-K filings.
$96M in FY2025 with a 5-year CAGR of +13.8%. Top quartile in the Health Care sector.
Improved from $125M to $96M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -12.6%
- 5-Year CAGR
- +13.8%
- 10-Year CAGR
- -
Sector benchmark
-55.0% below sector average
Key checks
Key Insights
- Emergent BioSolutions Inc.'s depreciation & amortization has declined for 3 consecutive years.
- 5-year CAGR of +13.8%, indicating consistent growth.
- In FY2025, depreciation & amortization decreased 11.9% year-over-year.
- Ranks #17 out of 168 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $95.8M | -11.9% |
| FY2024 | $108.8M | -13.0% |
| FY2023 | $125.1M | -12.7% |
| FY2022 | $143.3M | +15.8% |
| FY2021 | $123.8M | +147.1% |
| FY2020 | $50.1M | +1.2% |
| FY2019 | $49.5M | +76.6% |
| FY2018 | $28.0M | -13.0% |
| FY2017 | $32.2M | +14.9% |
| FY2016 | $28.0M | +18.1% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026